We are on a mission to improve patient outcomes
We create novel medicines that benefit patients in need
About ResoTher Pharma
We target neutrophil driven inflamation and act as resolution therapy
ResoTher Pharma is a privately held biotechnology company located in Copenhagen, Denmark. The company is focused on discovering and developing peptide-based drugs as resolution therapy for diseases where inflammation plays a key pathological role.
ResoTher Pharma wins Innobooster award
ResoTher Pharma is pleased to announce that the company has [...]
ResoTher Pharma featured at StartUp Spotlight BioEurope Spring
ResoTher Pharma has been selected as one of the up-and-coming [...]
Paul Hargreaves joins ResoTher Pharma as Chief Development Officer
ResoTher Pharma is pleased to announce that Paul Hargreaves, MSc, [...]
Latest News
ResoTher Pharma wins Innobooster award
ResoTher Pharma is pleased to announce that the company has [...]
ResoTher Pharma featured at StartUp Spotlight BioEurope Spring
ResoTher Pharma has been selected as one of the up-and-coming [...]
Paul Hargreaves joins ResoTher Pharma as Chief Development Officer
ResoTher Pharma is pleased to announce that Paul Hargreaves, MSc, [...]
